Product
Ceftibuten
Aliases
Ceftibuten Placebo
4 clinical trials
2 indications
Indication
Bacterial InfectionsIndication
pharmacokineticsClinical trial
A Phase 1, Open-label, Single-dose Study to Determine the Safety and Pharmacokinetics of ORAvance (Ceftibuten/Xeruborbactam Oral Prodrug [QPX7831]) in Participants With Renal ImpairmentStatus: Not yet recruiting, Estimated PCD: 2025-02-01
Clinical trial
A Phase 1, Open-Label, Drug-drug Interaction, and Randomized, Double-blind, Controlled, Multiple-dose Pharmacokinetics and Safety Study of Xeruborbactam Oral Prodrug (QPX7831) in Combination With Ceftibuten in Healthy Adult ParticipantsStatus: Recruiting, Estimated PCD: 2024-09-12
Clinical trial
VNRX-7145-103: A Phase 1, Open-label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal FunctionStatus: Completed, Estimated PCD: 2023-11-21
Clinical trial
VNRX-7145-104: an Open-label, Cross-over Study to Evaluate the Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Ceftibuten/VNRX-7145 in Healthy Participants.Status: Completed, Estimated PCD: 2023-02-06